Clinical Trial Update: Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration

View source ↗

Summary

An update on a Basel-based clinical trial investigating the progression of pseudoxanthoma elasticum–associated choroidal and retinal degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudoxanthoma Elasticum

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Pseudoxanthoma Elasticum | Status: ACTIVE_NOT_RECRUITING